Search research articles
Contact Us
Filters
Showing results (91-100 of 97) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 97 results.
Biorxiv : the Preprint Server for Biology
|
February 17, 2023
GSK-3 inhibitor elraglusib enhances tumor-infiltrating immune cell activation in tumor biopsies and synergizes with anti-PD-L1 in a murine model of colorectal cancer
Kelsey E Huntington, Anna D Louie, Praveen R Srinivasan, et al.
International Journal of Molecular Sciences
|
July 14, 2023
GSK-3 Inhibitor Elraglusib Enhances Tumor-Infiltrating Immune Cell Activation in Tumor Biopsies and Synergizes with Anti-PD-L1 in a Murine Model of Colorectal Cancer
Kelsey E Huntington, Anna D Louie, Praveen R Srinivasan, et al.
Biochemical Society Transactions
|
January 11, 2023
Therapeutic targeting of TRAIL death receptors
Francesca Di Cristofano, Andrew George, Vida Tajiknia, et al.
Mabs
|
April 15, 2026
Preclinical characterization of AZD1163, a first-in-class anti-PAD2/4 bispecific antibody for the treatment of rheumatoid arthritis
Gary P Sims, Lacie Scaletta, John Andrews, et al.
The Journal of Clinical Investigation
|
January 14, 2025
TRAIL agonists rescue mice from radiation-induced lung, skin, or esophageal injury
Jillian Strandberg, Anna Louie, Seulki Lee, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
January 17, 2018
The rate of telomere loss is related to maximum lifespan in birds
Gianna M Tricola, Mirre J P Simons, Els Atema, et al.
Nature Communications
|
September 15, 2015
Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation
E Suzanne Cohen, Ian C Scott, Jayesh B Majithiya, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 97) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 97 results.
Biorxiv : the Preprint Server for Biology
|
February 17, 2023
GSK-3 inhibitor elraglusib enhances tumor-infiltrating immune cell activation in tumor biopsies and synergizes with anti-PD-L1 in a murine model of colorectal cancer
Kelsey E Huntington, Anna D Louie, Praveen R Srinivasan, et al.
International Journal of Molecular Sciences
|
July 14, 2023
GSK-3 Inhibitor Elraglusib Enhances Tumor-Infiltrating Immune Cell Activation in Tumor Biopsies and Synergizes with Anti-PD-L1 in a Murine Model of Colorectal Cancer
Kelsey E Huntington, Anna D Louie, Praveen R Srinivasan, et al.
Biochemical Society Transactions
|
January 11, 2023
Therapeutic targeting of TRAIL death receptors
Francesca Di Cristofano, Andrew George, Vida Tajiknia, et al.
Mabs
|
April 15, 2026
Preclinical characterization of AZD1163, a first-in-class anti-PAD2/4 bispecific antibody for the treatment of rheumatoid arthritis
Gary P Sims, Lacie Scaletta, John Andrews, et al.
The Journal of Clinical Investigation
|
January 14, 2025
TRAIL agonists rescue mice from radiation-induced lung, skin, or esophageal injury
Jillian Strandberg, Anna Louie, Seulki Lee, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
January 17, 2018
The rate of telomere loss is related to maximum lifespan in birds
Gianna M Tricola, Mirre J P Simons, Els Atema, et al.
Nature Communications
|
September 15, 2015
Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation
E Suzanne Cohen, Ian C Scott, Jayesh B Majithiya, et al.
Page
of 10